2021年12月13日 · Ebixa should be taken orally once daily at the same time each day. The solution can be taken with or without food. The solution must not be poured or pumped into the mouth directly from the bottle or the pump, but should be dosed onto a spoon or into a glass of water using the pump.

Ebixa is a medicine that contains the active substance memantine hydrochloride. It is available as tablets (5 mg, 10 mg, 15 mg and 20 mg). Ebixa is also available as an oral solution, which is supplied with a pump that delivers 5 mg memantine hydrochloride with each activation.

Ebixa is also available as an oral solution, which is supplied with a pump that delivers 5 mg memantine hydrochloride with each activation. What is Ebixa used for? Ebixa is used to treat patients with moderate to severe Alzheimer’s disease.

2025年1月18日 · Memantine helps to ease the symptoms of dementia in Alzheimer's disease. Take one dose every day, at the same time of day each day. You can take memantine either before or after meals. You will be given a small dose when you first start treatment. This will gradually be increased over the following few weeks. Can memantine cause problems?

The recommended dose of Ebixa for adults and older people is four pump actuations, equivalent to 20 mg once a day. In order to reduce the risk of side effects this dose is achieved gradually by the

Ebixa is also available as an oral solution, which is supplied with a pump that delivers 5 mg memantine hydrochloride with each activation. What is Ebixa used for? Ebixa is used to treat patients with moderate to severe Alzheimer’s disease.

Ebixa 5 mg/pump actuation oral solution. Oral solution. The solution is clear and colourless to light yellowish. Each pump actuation delivers 0.5 ml of solution which contains 5 mg of memantine hydrochloride which is equivalent to 4.16 mg memantine.

Ebixa is intended for the treatment of moderate to severe Alzheimer’s disease. Therapeutic group: NMDA receptor antagonist. Ebixa belongs to a group of medicines for the treatment of dementia. Memory loss in Alzheimer’s disease is due to a disturbance of message signals in the brain.

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.

2018年7月6日 · Ebixa acts on these NMDA-receptors improving the transmission of nerve signals and the memory. Ebixa is used for the treatment of patients with moderate to severe Alzheimer’s disease. 2.